Avantor SG&A Expenses 2018-2025 | AVTR

Avantor sg&a expenses for the twelve months ending March 31, 2025 were $1.604B, a 4.37% increase year-over-year.

  • Avantor annual sg&a expenses for 2024 were $1.641B, a 8.93% increase from 2023.
  • Avantor annual sg&a expenses for 2023 were $1.507B, a 2.31% increase from 2022.
  • Avantor annual sg&a expenses for 2022 were $1.473B, a 3.78% decline from 2021.

Avantor SG&A Expenses 2018-2025 | AVTR

  • Avantor annual sg&a expenses for 2024 were $1.641B, a 8.93% increase from 2023.
  • Avantor annual sg&a expenses for 2023 were $1.507B, a 2.31% increase from 2022.
  • Avantor annual sg&a expenses for 2022 were $1.473B, a 3.78% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$146.1B
CVS Health (CVS)$78.8B
Elevance Health (ELV)$66.1B
Cencora (COR)$56.6B
DiDi Global (DIDIY)$24.2B
Labcorp Holdings (LH)$22.1B
Natera (NTRA)$19.2B
BioMerieux (BMXMF)$17.1B
EUROFINS SCIENT (ERFSF)$14.9B
ICON (ICLR)$14.7B
CochLear (CHEOY)$13.3B
Solventum (SOLV)$12.6B
Medpace Holdings (MEDP)$12.3B
Revvity (RVTY)$10.7B
Viatris (VTRS)$10.6B
Sonic Healthcare (SKHHY)$8.9B
Charles River Laboratories (CRL)$8.7B
HealthEquity (HQY)$8.5B
Caris Life Sciences,�Inc (CAI)$7.5B
Bausch + Lomb (BLCO)$4.9B
Amplifon S.p.A (AMFPF)$3.9B
BrightSpring Health Services (BTSG)$3.7B
Sotera Health (SHC)$3.4B
GeneDx Holdings (WGS)$3B
Surgery Partners (SGRY)$2.9B
Concentras Parent (CON)$2.6B
Organon (OGN)$2.6B
Alignment Healthcare (ALHC)$2.6B
Progyny (PGNY)$2B
Premier (PINC)$1.8B